RICARDO MARTINEZ: Open Payments
NPI 1003128828 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 15 payments from 9 companies in 2025. Trend: 2023 $551 · 2024 $385 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $73 |
| Novo Nordisk Inc | 3 | $56 |
| ABBVIE INC. | 2 | $30 |
| ABIOMED | 1 | $26 |
| PFIZER INC. | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| Abbott Laboratories | 1 | $14 |
Products named: OTEZLA, EVENITY, PAXLOVID, Ozempic, Korlym, Rybelsus, Wegovy, QULIPTA.
Industry payments across FL — which companies pay providers there.
